Matthew Cooperberg
University of California, San Francisco
H-index: 87
North America-United States
Top articles of Matthew Cooperberg
Title | Journal | Author(s) | Publication Date |
---|---|---|---|
Expert perspectives on controversies in castration-sensitive prostate cancer management: narrative review and report of the first US prostate cancer conference part 1 | E David Crawford Alan H Bryce Maha H Hussain Neeraj Agarwal Himisha Beltran | 2024/4/1 | |
PD29-11 VARIATIONS IN GENOMIC EXPRESSION PROFILES BY AGE, RACE, GLEASON GRADE GROUP, AND GEOGRAPHY AMONG MEN WITH PROSTATE CANCER | The Journal of Urology | Samuel L Washington Yang Liu James Proudfoot Elai Davicioni Matthew R Cooperberg | 2024/5 |
PD19-05 SMARTER SCREENING AND TREATMENT (S3T): MITIGATING HARM VIA AGE-& BASELINE-PROSTATE SPECIFIC ANTIGEN-STRATIFIED SCREENING | The Journal of Urology | James Nie Nynikka R Palmer Rena J Pasick Maria Byron Claire M de la Calle | 2024/5 |
How older men live with stress urinary incontinence: Patient experience and navigation to treatment | Neurourology and Urodynamics | Nathan M Shaw Benjamin N Breyer Louise C Walter Rebecca L Sudore Anne M Suskind | 2024/1 |
Pre-surgical 68Ga-PSMA-11 PET for biochemical recurrence risk assessment: A surrogate of pelvic lymph node dissection? Follow-up analysis of a multicenter … | Loic Djaileb Wesley Robert Armstrong Daniel Thompson Andrei Gafita Andrea Farolfi | 2024/2/1 | |
Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2 | Alan H Bryce E David Crawford Neeraj Agarwal Maha H Hussain Himisha Beltran | 2024/4/1 | |
MP34-01 BASELINE PROSTATE-SPECIFIC ANTIGEN SCREENING VALUES IN TRANSGENDER WOMEN ON GENDER-AFFIRMING HORMONE THERAPY: A NATIONAL COHORT STUDY | The Journal of Urology | Farnoosh Nik-Ahd Amanda de Hoedt Christi Butler Jennifer T Anger Peter R Carroll | 2024/5 |
MP58-18 DOES EQUAL ACCESS MEAN EQUAL ACCESS TO SECONDARY TREATMENTS AFTER BIOCHEMICAL RECURRENCE (BCR) FOLLOWING RADICAL PROSTATECTOMY (RP) | The Journal of Urology | Anael Rizzo Shakiba Eslamimehr Christopher L Amling William J Aronson Christopher Kane | 2024/5 |
Can early prostate cancer screening help address mortality disparities among Black men? | Matthew R Cooperberg | 2024/1/1 | |
Initial Experience with 68Ga-FAP-2286 PET Imaging in Patients with Urothelial Cancer | Journal of Nuclear Medicine | Vadim S Koshkin Vipul Kumar Brad Kline Domenique Escobar Maya Aslam | 2024/2/1 |
Transcriptomic heterogeneity of expansile cribriform and other Gleason Pattern 4 prostate cancer subtypes | European Urology Oncology | Meera R Chappidi Martin Sjöström Nancy Y Greenland Janet E Cowan Avi S Baskin | 2024/4/1 |
PD26-12 PERSISTENT NEED FOR SYSTEMATIC BIOPSY FOR THOSE ON ACTIVE SURVEILLANCE FOR EARLY-STAGE PROSTATE CANCER | The Journal of Urology | Mary Fakunle Janet Cowan Samuel Washington Katsuto Shinohara Hao Nguyen | 2024/5 |
PD13-06 IMPLEMENTATION OF PRACTICE-LEVEL INTERVENTIONS FOR LOW-RISK PROSTATE CANCER IN A COMMUNITY PRACTICE | The Journal of Urology | Franklin D Gaylis Michael Leapman Shellie D Ellis Steven Hu Matthew R Cooperberg | 2024/5 |
Multi-institutional Development and External Validation of a Machine Learning Model for the Prediction of Distant Metastasis in Patients Treated by Salvage Radiotherapy for … | European urology focus | Ali Sabbagh Derya Tilki Jean Feng Hartwig Huland Markus Graefen | 2024/1/1 |
The impact of genomic biomarkers on a clinical risk prediction model for upgrading/upstaging among men with favorable‐risk prostate cancer | Cancer | Avery E Braun June M Chan John Neuhaus Janet E Cowan Stacey A Kenfield | 2024/1/27 |
Contemporary risk of biochemical recurrence after radical prostatectomy in the active surveillance era | Urologic Oncology: Seminars and Original Investigations | Sanjay Das Michael Luu Martha Terris Zachary Klaassen Christopher J Kane | 2024/3/15 |
MP07-14 DEVELOPMENT OF A GENERATIVE ARTIFICIAL INTELLIGENCE DATA PIPELINE TO AUTOMATE THE CAPTURE OF UNSTRUCTURED MRI DATA FOR PROSTATE CANCER CARE | The Journal of Urology | Anobel Y Odisho Andrew W Liu William A Pace Robert Krumm Janet E Cowan | 2024/5 |
PD13-01 DETERMINING LONG-TERM PROSTATE CANCER OUTCOMES FOR ACTIVE SURVEILLANCE PATIENTS WITHOUT EARLY DISEASE PROGRESSION: WHEN TO SLOW OR STOP SURVEILLANCE | The Journal of Urology | Kevin Shee Janet E Cowan Lufan Wang Samuel L Washington III Katsuto Shinohara | 2024/5 |
MP34-17 CONSIDERING THE UNCOUNTED: CHARACTERISTICS OF US COUNTIES INCLUDED VS. NOT INCLUDED IN SEER | The Journal of Urology | Avery E Braun Lufan Wang Samuel L Washington Matthew R Cooperberg | 2024/5 |
Patient experiences with tissue‐based genomic testing during active surveillance for prostate cancer | BJUI compass | Michael S Leapman Ryan Sutherland Cary P Gross Xiaomei Ma Tyler M Seibert | 2024/1 |